131 related articles for article (PubMed ID: 20822954)
1. CA125--a test with a change of heart.
Sikaris KA
Heart Lung Circ; 2011 Oct; 20(10):634-40. PubMed ID: 20822954
[TBL] [Abstract][Full Text] [Related]
2. CA125 levels among patients with advanced heart failure: an emerging independent predictor for survival.
Turgut O; Tandogan I; Yilmaz MB; Gul I; Gurlek A
Int J Cardiol; 2010 Nov; 145(1):71. PubMed ID: 19446349
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of CA125 in advanced heart failure patients.
Monteiro S; Franco F; Costa S; Monteiro P; Vieira H; Coelho L; Oliveira L; Providência LA
Int J Cardiol; 2010 Apr; 140(1):115-8. PubMed ID: 19285353
[TBL] [Abstract][Full Text] [Related]
4. Heart failure in patients with aortic stenosis: clinical and prognostic significance of carbohydrate antigen 125 and brain natriuretic peptide measurement.
Antonini-Canterin F; Popescu BA; Popescu AC; Beladan CC; Korcova R; Piazza R; Cappelletti P; Rubin D; Cassin M; Faggiano P; Nicolosi GL
Int J Cardiol; 2008 Aug; 128(3):406-12. PubMed ID: 17662495
[TBL] [Abstract][Full Text] [Related]
5. [Natriuretic peptides--new diagnostic markers in heart disease].
Angermann CE; Ertl G
Herz; 2004 Sep; 29(6):609-17. PubMed ID: 15912436
[TBL] [Abstract][Full Text] [Related]
6. Comparative analysis of CA125, tissue polypeptide specific antigen, and soluble interleukin-2 receptor alpha levels in sera, cyst, and ascitic fluids from patients with ovarian carcinoma.
Sedlaczek P; Frydecka I; Gabryś M; Van Dalen A; Einarsson R; Harłozińska A
Cancer; 2002 Nov; 95(9):1886-93. PubMed ID: 12404282
[TBL] [Abstract][Full Text] [Related]
7. Soluble epidermal growth factor receptor (sEGFR) [corrected] and cancer antigen 125 (CA125) as screening and diagnostic tests for epithelial ovarian cancer.
Baron AT; Boardman CH; Lafky JM; Rademaker A; Liu D; Fishman DA; Podratz KC; Maihle NJ
Cancer Epidemiol Biomarkers Prev; 2005 Feb; 14(2):306-18. PubMed ID: 15734951
[TBL] [Abstract][Full Text] [Related]
8. Serum level of tumor marker carbohydrate antigen-CA125 in heart failure.
Durak-Nalbantic A; Resic N; Kulic M; Pecar E; Zvizdic F; Dzubur A; Dilic M; Gojak R; Sokolovic S; Hodzic E; Brdjanovic S
Med Arch; 2013; 67(4):241-4. PubMed ID: 24520743
[TBL] [Abstract][Full Text] [Related]
9. Clinical value of CYFRA21-1, NSE, CA15-3, CA19-9 and CA125 assay in the elderly patients with pleural effusions.
Li CS; Cheng BC; Ge W; Gao JF
Int J Clin Pract; 2007 Mar; 61(3):444-8. PubMed ID: 17313612
[TBL] [Abstract][Full Text] [Related]
10. Serum cancer antigen 125 in patients with pleural effusions.
How SH; Liam CK; Jamalludin AR; Chin SP; Zal AB
Med J Malaysia; 2006 Dec; 61(5):558-63. PubMed ID: 17623956
[TBL] [Abstract][Full Text] [Related]
11. Antigen carbohydrate 125 in heart failure: not just a surrogate for serosal effusions?
Núñez J; Miñana G; González M; Garcia-Ramón R; Sanchis J; Bodí V; Núñez E; Chorro FJ; Llàcer A; Miguel A
Int J Cardiol; 2011 Feb; 146(3):473-4. PubMed ID: 21193243
[No Abstract] [Full Text] [Related]
12. Factors predictive of elevated serum CA125 levels in patients with epithelial ovarian cancer.
Bouanène H; Harrabi I; Ferchichi S; Ben Limem H; Miled A
Bull Cancer; 2007 Jul; 94(7):E18-22. PubMed ID: 17723943
[TBL] [Abstract][Full Text] [Related]
13. The alteration of dialysate cancer antigen 125 concentration under a biocompatible bicarbonate peritoneal dialysis solution and the preservation of the mesothelial cell viability.
Theodoridis M; Passadakis P; Kriki P; Gioka T; Panagoutsos S; Mourvati E; Thodis E; Kantartzi K; Vargemezis V
Ren Fail; 2008; 30(2):161-7. PubMed ID: 18300115
[TBL] [Abstract][Full Text] [Related]
14. A comparative study of serum alpha-beta A immunoreactive inhibin and tumor-associated antigens CA125 and CEA in ovarian cancer.
Phocas I; Sarandakou A; Sikiotis K; Rizos D; Kalambokis D; Zourlas PA
Anticancer Res; 1996; 16(6B):3827-31. PubMed ID: 9042265
[TBL] [Abstract][Full Text] [Related]
15. The use of mucin-specific monoclonal antibodies and lectins in the detection of tumor-associated serum markers in gynecological cancer.
Devine PL; McGuckin MA; Ramm LE; Harada H; Ward BG
Cancer Biochem Biophys; 1993 Sep; 13(4):221-38. PubMed ID: 8521372
[TBL] [Abstract][Full Text] [Related]
16. Serum, pleural effusion, and ascites CA-125 levels in ovarian cancer and nonovarian benign and malignant diseases: a comparative study.
Topalak O; Saygili U; Soyturk M; Karaca N; Batur Y; Uslu T; Erten O
Gynecol Oncol; 2002 Apr; 85(1):108-13. PubMed ID: 11925128
[TBL] [Abstract][Full Text] [Related]
17. Comparison between soluble tumor necrosis factor receptors and CA125 in peritoneal fluids as a marker for epithelial ovarian cancer.
Onsrud M; Shabana A; Austgulen R; Nustad K
Gynecol Oncol; 1995 May; 57(2):183-7. PubMed ID: 7729731
[TBL] [Abstract][Full Text] [Related]
18. Elevated serum CA-125 levels in hemodialysis patients with peritoneal, pleural, or pericardial fluids.
Sevinc A; Buyukberber S; Sari R; Kiroglu Y; Turk HM; Ates M
Gynecol Oncol; 2000 May; 77(2):254-7. PubMed ID: 10785474
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of serum CA125 levels in diffuse large B-cell lymphoma: potential role of a new sex- and age-adjusted reference value.
Gutiérrez A; Martínez-Serra J; Barceló B; Sampol A; Viñas L; González G; Bea MD; Amat JC; Martín J; Ramos R; Bautista A; Forteza-Rey J; Rodríguez J; Besalduch J
Int J Lab Hematol; 2010 Dec; 32(6 Pt 2):582-9. PubMed ID: 20201996
[TBL] [Abstract][Full Text] [Related]
20. Value of serum CA125 levels in patients with high-risk, early stage epithelial ovarian cancer.
Kang WD; Choi HS; Kim SM
Gynecol Oncol; 2010 Jan; 116(1):57-60. PubMed ID: 19818996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
